- Home
- UUU vs CMND Comparison
UUU vs CMND Comparison
Compare UUU & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUU
- CMND
- Stock Information
- Founded
- UUU 1969
- CMND 2017
- Country
- UUU United States
- CMND Canada
- Employees
- UUU N/A
- CMND N/A
- Industry
- UUU Electronic Components
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- UUU Technology
- CMND Health Care
- Exchange
- UUU Nasdaq
- CMND Nasdaq
- Market Cap
- UUU 11.3M
- CMND 5.3M
- IPO Year
- UUU N/A
- CMND N/A
- Fundamental
- Price
- UUU $5.38
- CMND $0.99
- Analyst Decision
- UUU
- CMND
- Analyst Count
- UUU 0
- CMND 0
- Target Price
- UUU N/A
- CMND N/A
- AVG Volume (30 Days)
- UUU 192.3K
- CMND 113.5K
- Earning Date
- UUU 11-18-2025
- CMND 09-11-2025
- Dividend Yield
- UUU 19.08%
- CMND N/A
- EPS Growth
- UUU N/A
- CMND N/A
- EPS
- UUU 1.19
- CMND N/A
- Revenue
- UUU $22,789,285.00
- CMND N/A
- Revenue This Year
- UUU N/A
- CMND N/A
- Revenue Next Year
- UUU N/A
- CMND N/A
- P/E Ratio
- UUU $4.22
- CMND N/A
- Revenue Growth
- UUU 30.84
- CMND N/A
- 52 Week Low
- UUU $1.22
- CMND $0.80
- 52 Week High
- UUU $8.27
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- UUU 51.93
- CMND 49.31
- Support Level
- UUU $4.80
- CMND $0.96
- Resistance Level
- UUU $6.00
- CMND $1.08
- Average True Range (ATR)
- UUU 0.63
- CMND 0.05
- MACD
- UUU 0.02
- CMND 0.00
- Stochastic Oscillator
- UUU 44.08
- CMND 46.72
About UUU Universal Security Instruments Inc.
Universal Safety Products Inc is a U.S.-based importer and distributor of home safety devices such as ventilation fans and ground fault circuit interrupters.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.